We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




靶向荧光成像化合物可检测癌症活细胞

By LabMedica International staff writers
Posted on 16 Jun 2009
荧光成像化合物只有当它在活体细胞内部时才起作用,而当细胞死亡或受到破坏后将不在产生荧光。通过对这种化合物进行工程设计,可以使其靶向特定类型的癌细胞。

这种新型化合物使得科学家能够可视化扩散导老鼠肺部的乳腺癌细胞。这种化合物可结合存在于某些乳腺癌细胞表面的名为HER2的蛋白质,只有当化合物进入到活体细胞内部时才发出荧光。这种靶向和激活方法使得科学家能够在乳腺癌的老鼠模型中检测特定类型的活体癌细胞

以前开发的可在人体细胞中被激活的荧光化合物的局限性是,一旦开始发出荧光后就将持续发光,甚至在它们散布到新位置后也是如此。 这就非常难以将活肿瘤细胞与正常组织、死亡、或受损的肿瘤细胞区分开。

研究工作是在日本和隶属美国国家卫生研究所(Bethesda, MD, USA; www.nih.gov)的国家癌症研究所(NCI)进行的。开发出成像化合物的科研组由来自国家癌症研究所癌症研究中心(CCR)的Hisataka Kobayashi博士领导,同时与东京大学(Japan; (www.u-tokyo.ac.jp)的Yasuteru Urano博士合作。

"通过可视化药物是否击中其目标以及击中目标后是否可导致肿瘤缩小,这些(荧光成像)化合物或许可使得医生能够监视病人对癌症疗法的反应。"Kobayashi博士说。他又补充说:"与其它可激活的荧光化合物不同,我们的这种化合物包括独立起作用的一种目标药剂和一种发荧光的药剂。通过使用与细胞表面蛋白质结合后被靶向细胞内化的任何抗体或分子,我们可以使荧光药剂靶向任何不同类型的癌细胞。"

描述这种新化合物的论文发表在2008年12月7号的《自然药物》在线版。

Related Links:

美国卫生研究所
www.nih.gov
东京大学
www.u-tokyo.ac.jp
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.